-transparent.png){kind=logo}
The purified respiratory syncytial virus (RSV), Randall strain contained 10 polypeptides (72,000 molecular weight [72K], 66K, 48K, 42K, 40K, 36K, 30K, 23K, 18K, and 15K), 8 of which proved to be virus specific, and polypeptides 48K and 23K were glycosylated. In addition, a high-molecular-weight (150K), virus-specific glycopolypeptide was immunoprecipitated from RSV-infected cell lysate. The antibody response in human sera serially collected from children with primary RSV infection was mainly directed against the polypeptides 30K, 48K, and 72K. The immune response against the other viral proteins was also already detectable in the acute-phase sera. These results indicate that the immune response in RSV infection differs significantly from those for other diseases caused by paramyxoviruses.
R Vainionpää, and
O Meurman, and
H Sarkkinen
November 1981,
American journal of diseases of children (1960),
R Vainionpää, and
O Meurman, and
H Sarkkinen
July 2016,
Human vaccines & immunotherapeutics,
R Vainionpää, and
O Meurman, and
H Sarkkinen
September 1989,
Journal of clinical microbiology,
R Vainionpää, and
O Meurman, and
H Sarkkinen
January 1991,
Laboratornoe delo,
R Vainionpää, and
O Meurman, and
H Sarkkinen
May 2000,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R Vainionpää, and
O Meurman, and
H Sarkkinen
October 1998,
Epidemiology and infection,
R Vainionpää, and
O Meurman, and
H Sarkkinen
March 1989,
Journal of medical virology,
R Vainionpää, and
O Meurman, and
H Sarkkinen
September 1999,
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
R Vainionpää, and
O Meurman, and
H Sarkkinen
April 1990,
Journal of medical virology,
R Vainionpää, and
O Meurman, and
H Sarkkinen
March 1989,
The Journal of general virology,
